Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3734186015 | Ocrelizumab only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3734187012 | Product containing only ocrelizumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 2842471000001114 | Ocrelizumab (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2842481000001111 | Ocrelizumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ocrelizumab | Has active ingredient | Ocrelizumab | true | Inferred relationship | Existential restriction modifier | 1 | |
| Ocrelizumab | Is a | Product containing ocrelizumab | true | Inferred relationship | Existential restriction modifier | ||
| Ocrelizumab | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Ocrelizumab | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only ocrelizumab in parenteral dose form (medicinal product form) | Is a | True | Ocrelizumab | Inferred relationship | Existential restriction modifier | |
| Ocrelizumab 300mg/10ml solution for infusion vials | Is a | True | Ocrelizumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR